![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0802 | 1.90952380952 | 4.2 | 4.46 | 3.9901 | 14690 | 4.2292196 | CS |
4 | 0.0602 | 1.42654028436 | 4.22 | 4.46 | 3.7401 | 9599 | 4.16339949 | CS |
12 | 0.4302 | 11.174025974 | 3.85 | 4.5 | 3.51 | 6270 | 4.05739501 | CS |
26 | 1.1502 | 36.7476038339 | 3.13 | 4.74 | 3.13 | 5856 | 4.0952676 | CS |
52 | 0.5102 | 13.5331564987 | 3.77 | 5.97 | 2.8696 | 6293 | 4.10306588 | CS |
156 | -26.2198 | -85.966557377 | 30.5 | 56.8 | 2.40101 | 334427 | 34.48755092 | CS |
260 | -23.2198 | -84.4356363636 | 27.5 | 56.8 | 2.40101 | 733486 | 26.33257535 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions